1. Home
  2. FN vs RVMD Comparison

FN vs RVMD Comparison

Compare FN & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fabrinet

FN

Fabrinet

HOLD

Current Price

$662.58

Market Cap

23.7B

Sector

Utilities

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$155.33

Market Cap

19.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FN
RVMD
Founded
1999
2014
Country
Cayman Islands
United States
Employees
N/A
883
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.7B
19.2B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
FN
RVMD
Price
$662.58
$155.33
Analyst Decision
Buy
Strong Buy
Analyst Count
8
19
Target Price
$489.14
$135.05
AVG Volume (30 Days)
676.2K
2.8M
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
13.21
N/A
EPS
5.77
N/A
Revenue
$3,419,327,000.00
N/A
Revenue This Year
$36.87
N/A
Revenue Next Year
$18.16
$411.49
P/E Ratio
$119.16
N/A
Revenue Growth
18.60
N/A
52 Week Low
$167.33
$34.00
52 Week High
$708.20
$155.01

Technical Indicators

Market Signals
Indicator
FN
RVMD
Relative Strength Index (RSI) 62.63 88.14
Support Level $429.50 $93.39
Resistance Level N/A N/A
Average True Range (ATR) 38.52 4.77
MACD 12.34 7.00
Stochastic Oscillator 79.82 99.13

Price Performance

Historical Comparison
FN
RVMD

About FN Fabrinet

Fabrinet provides advance-level optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advance optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advance-level of packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: